A novel variant of DNM1L expanding the clinical phenotypic spectrum: a case report and literature review
- PMID: 38341530
- PMCID: PMC10858475
- DOI: 10.1186/s12887-023-04442-y
A novel variant of DNM1L expanding the clinical phenotypic spectrum: a case report and literature review
Abstract
Background: Mitochondrial diseases are heterogeneous in terms of clinical manifestations and genetic characteristics. The dynamin 1-like gene (DNM1L) encodes dynamin-related protein 1 (DRP1), a member of the GTPases dynamin superfamily responsible for mitochondrial and peroxisomal fission. DNM1L variants can lead to mitochondrial fission dysfunction.
Case presentation: Herein, we report a distinctive clinical phenotype associated with a novel variant of DNM1L and review the relevant literature. A 5-year-old girl presented with paroxysmal hemiplegia, astigmatism, and strabismus. Levocarnitine and coenzyme Q10 supplement showed good efficacy. Based on the patient's clinical data, trio whole-exome sequencing (trio-WES) and mtDNA sequencing were performed to identify the potential causative genes, and Sanger sequencing was used to validate the specific variation in the proband and her family members. The results showed a novel de novo heterozygous nonsense variant in exon 20 of the DNM1L gene, c.2161C>T, p.Gln721Ter, which is predicted to be a pathogenic variant according to the ACMG guidelines. The proband has a previously undescribed clinical manifestation, namely hemiparesis, which may be an additional feature of the growing phenotypic spectrum of DNM1L-related diseases.
Conclusion: Our findings elucidate a novel variant in DNM1L-related disease and reveal an expanding phenotypic spectrum associated with DNM1L variants. This report highlights the necessity of next generation sequencing for early diagnosis of patients, and that further clinical phenotypic and genotypic analysis may help to improve the understanding of DNM1L-related diseases.
Keywords: DNM1L gene; Mitochondrial diseases; Nonsense variant; Phenotypic spectrum.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10858475/bin/12887_2023_4442_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10858475/bin/12887_2023_4442_Fig2_HTML.gif)
Similar articles
-
[DNM1L gene variant caused encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1: three cases report and literature review].Zhonghua Er Ke Za Zhi. 2021 May 2;59(5):400-406. doi: 10.3760/cma.j.cn112140-20200921-00893. Zhonghua Er Ke Za Zhi. 2021. PMID: 33902225 Review. Chinese.
-
De Novo DNM1L Variant in a Teenager With Progressive Paroxysmal Dystonia and Lethal Super-refractory Myoclonic Status Epilepticus.J Child Neurol. 2018 Sep;33(10):651-658. doi: 10.1177/0883073818778203. Epub 2018 Jun 7. J Child Neurol. 2018. PMID: 29877124 Free PMC article. Review.
-
A novel de novo dominant negative mutation in DNM1L impairs mitochondrial fission and presents as childhood epileptic encephalopathy.Am J Med Genet A. 2016 Aug;170(8):2002-11. doi: 10.1002/ajmg.a.37721. Epub 2016 May 4. Am J Med Genet A. 2016. PMID: 27145208 Free PMC article.
-
Postnatal microcephaly and pain insensitivity due to a de novo heterozygous DNM1L mutation causing impaired mitochondrial fission and function.Am J Med Genet A. 2016 Jun;170(6):1603-7. doi: 10.1002/ajmg.a.37624. Epub 2016 Mar 17. Am J Med Genet A. 2016. PMID: 26992161
-
Missense variants in the middle domain of DNM1L in cases of infantile encephalopathy alter peroxisomes and mitochondria when assayed in Drosophila.Hum Mol Genet. 2016 May 1;25(9):1846-56. doi: 10.1093/hmg/ddw059. Epub 2016 Feb 29. Hum Mol Genet. 2016. PMID: 26931468 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous